Previously, we showed in HCC cell line models that GEP regulated the expression levels of hepatic CSC markers CD133 and EpCAM, pluripotency-associated signaling molecules β-catenin, SOX2, Oct4 and Nanog at protein levels [17]. This evidence concerns the gene SOX2 and hepatocellular carcinoma.